Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

289
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
289
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
194
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

3.6K
Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
3.6K
Mutations01:39

Mutations

83.7K
Overview
83.7K
Glucose Transporters01:27

Glucose Transporters

22.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

349
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
349

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry.

The Lancet. Respiratory medicine·2026
Same author

Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective (part 2: special situations/respiratory complications).

Respiratory medicine·2026
Same author

Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis.

British journal of clinical pharmacology·2026
Same author

Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Classification and regression trees to identify COPD subgroups in clinical trial populations: insights from the IMPACT trial.

BMC pulmonary medicine·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026

相关实验视频

Updated: Jul 20, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

570

囊性纤维化症是什么

Isabelle Fajac1, Pierre-Régis Burgel1

  • 1Department of Respiratory Medicine and National Cystic Fibrosis Reference Centre, Cochin Hospital, Assistance Publique Hôpitaux de Paris, 27 rue du faubourg Saint-Jacques, 75014 Paris, France; Université Paris Cité, Inserm U1016, Institut Cochin, 24 rue du faubourg Saint-Jacques, 75014 Paris, France; ERN-LUNG, CF Core Network, Frankfurt, Germany.

Presse medicale (Paris, France : 1983)
|July 29, 2023
PubMed
概括
此摘要是机器生成的。

囊性纤维化 (CF) 是一种影响多个器官的遗传性疾病. 新的CFTR调节器疗法可以改善肺功能和生存,但对罕见变异的获取和有效性仍然是挑战.

关键词:
支气管切除症是一种支气管切除症.在CFTR调节器.囊性纤维化跨膜导电调节器 (CFTR)伪omonas aeruginosa 这种类型的病毒.

更多相关视频

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

10.7K
Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

14.6K

相关实验视频

Last Updated: Jul 20, 2025

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression
08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

570
Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

10.7K
Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

14.6K

科学领域:

  • 医学遗传学 医学遗传学
  • 肺部病理学 肺部病理学
  • 胃肠病学 胃肠病学

背景情况:

  • 囊性纤维化 (CF) 是一种由囊性纤维化跨膜导电性调节器 (CFTR) 基因突变引起的自体逆向遗传疾病.
  • CFTR 蛋白质功能障碍会破坏离子运输,导致多器官疾病,主要影响呼吸和消化系统.
  • 呼吸道并发症,包括粘液堵塞,慢性感染和支气管炎,导致渐进的肺损伤,是CF患者死亡的主要原因.

研究的目的:

  • 审查囊性纤维化 (CF) 疾病和护理的现状.
  • 讨论CF管理和治疗的未来前景.

主要方法:

  • 本综述综合了有关CF病理生理学,临床表现和治疗进展的当前文献.
  • 它侧重于多学科护理的影响和CFTR调节器疗法的出现.
  • 该审查还解决了当前CF护理的挑战,包括治疗机会和不断变化的患者群体.

主要成果:

  • 在过去的50年里,多学科护理显著改善了CF患者的治疗结果.
  • CFTR调节器代表了一项重大治疗进步,部分恢复了CFTR功能,改善了临床结果和肺功能.
  • 尽管取得了进展,但对于CFTR调节器的公平获取,它们在罕见CFTR变异中的有效性以及对老化CF群体的护理调整仍然存在挑战.

结论:

  • CFTR调节器已经改变了CF护理,提供了更好的生存率和生活质量.
  • 解决与特定患者群体的成本,获取和有效性相关的挑战至关重要.
  • 未来的战略必须侧重于个性化医疗,创新疗法,并调整医疗保健系统以满足老龄化CF人口的需求.